Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Watch On-Demand
CE Webinar
Prescriptions for High Drug Costs
On-Demand
Drugs prices continue to drive higher claims costs.
Workers' Comp
Article
Ask The Pharmacist: Anti-Seizure Medications for Pain Management in Workers’ Compensation
How are seizure drugs used for pain management in workers' comp? Opioids are often prescribed for moderate-to-severe pain, and while opio
Workers' Comp
Podcast
2022 Midterm Elections – Takeaways That Will Impact Comp and Auto in 2023
It’s been a month since the midterm elections, and while most Americans, except for Georgians, enjoyed a break from political ads, it took a little
PC 360
In the News
The Mental Side of an Injured Worker’s Recovery
Mitchell
News Release
Mitchell Selected as the Preferred North American Technology Provider of Vale’s Paintless Dent Repair (PDR) Technician Certification Program
Designation now extends beyond the US to Canada through agreement with Dented Paintless Repairs SAN DIEGO, Calif.—
Workers' Comp
News Release
Changes to the ODG Drug Formulary Impact Opioid Class
Effective December 2, 2022, the Official Disability Guidelines (ODG) Drug Formulary updated the opioid drug class.